Nazia Khan

Nazia Khan

Sheppard Mullin Richter & Hampton LLP

Contact
View Bio
RSS

Latest Posts › Classification

Share:

Reclassifying Cannabis as a Schedule III Substance – Will the DEA Agree?

On August 29, 2023, less than one year after President Biden’s directive to federal officials, including the U.S. Department of Health and Human Services (“HHS”) and the U.S. Attorney general, to conduct a review of cannabis’...more

9/1/2023  /  Cannabis Products , Classification , Controlled Substances , Controlled Substances Act , DEA , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Marijuana , Medical Marijuana , Schedule I Drugs
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide